Venture Partner, London
Roberto is a research biologist and is currently a Senior Research Fellow at the National Heart and Lung Institute, Imperial College London. Roberto also acts as an advisor to Brandon Capital Partners. Prior to this Roberto was Vice President in GSK’s Respiratory Therapy Area based in Stevenage in the UK where his role covered drug discovery from target identification through to proof of concept studies in man.
Before joining GSK Roberto was CEO of the UK Medical Research Council’s technology transfer arm, MRCT. The MRCT is responsible for managing intellectual property, licensing activities, creating spin out companies such as Heptares and developing an internal drug discovery group. Prior to this he spent 5 years in the venture industry, latterly as an advisor to Apax Partners’ life sciences team having previously worked with Abingworth as an entrepreneur in residence helping start up a number of companies including Astex Therapeutics, Lorantis and Chroma Therapeutics. Before this he was Head of the Cell Biology unit at GlaxoWellcome, following post-doctoral research at the Institut de Biochimie, Universite de Lausanne and at Liverpool University. Roberto Solari has BSc and PhD in Physiology and Cell Biology from Nottingham University.